Zepp Health Third Quarter 2024 Earnings: US$0.82 loss per share (vs US$0.027 profit in 3Q 2023)

Simply Wall St

November 20, 2024

Zepp Health (NYSE:ZEPP) Third Quarter 2024 Results

Key Financial Results

Revenue: US$42.5m (down 49% from 3Q 2023).
Net loss: US$13.3m (down from US$407.5k profit in 3Q 2023).
US$0.82 loss per share (down from US$0.027 profit in 3Q 2023).

earnings-and-revenue-growth — NYSE:ZEPP Earnings and Revenue Growth November 20th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Zepp Health Earnings Insights

Looking ahead, revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 7.2% growth forecast for the Electronic industry in the US.

Performance of the American Electronic industry.

The company's shares are down 15% from a week ago.

Risk Analysis

We don't want to rain on the parade too much, but we did also find 2 warning signs for Zepp Health that you need to be mindful of.

Valuation is complex, but we're here to simplify it.

Discover if Zepp Health might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.